ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-03574
製品名称
MERS-CoV Spike/S1 Protein (aa 1-725, His)
タンパク質名
MERS-CoV Spike/S1
Species
MERS-CoV
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms coronavirus spike Protein, MERS-CoV, coronavirus s2 Protein, MERS-CoV, ncov s1 Protein, MERS-CoV, ncov RBD Protein, MERS-CoV, ncov spike Protein, MERS-CoV, cov spike Protein, MERS-CoV, ncov s2 Protein, MERS-CoV, coronavirus s1 Protein, MERS-CoV, RBD Prote
Characteristics Measured by its binding ability in a functional ELISA. Immobilized Spike Protein S1 (aa 1-725) at 2 μg/ml (100 μl/well) can bind biotinylated Fc-DPP4 . The EC50 of biotinylated Fc-DPP4 is 15-60 ng/ml.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 93.30%
Description MERS-CoV Spike/S1 Protein (aa 1-725, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 79.9 kDa and the accession number is K0BRG7.
Reference Shen S,et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.,Du L,et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.,Xiao X,et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
URL https://www.targetmol.com/recombinant-protein/mers_cov_spike_s1_protein_s1_subunit_aa_1_725_his_tag_